Psychedelics show comparable efficacy to antidepressants, but systemic barriers hinder equitable access
Original framing: “Psychedelics may be no better than antidepressants for depression” — New Scientist
The criminalization of psychedelics in the 20th century was driven by political and moral panic, not scientific evidence. This history continues to shape current regulatory barriers to research and treatment.
The comparative efficacy of psychedelics and antidepressants is not the central issue—what matters is the systemic exclusion of alternative healing modalities from mainstream mental health care.
Indigenous knowledge, historical context, and cross-cultural practices reveal a broader vision of healing that integrates mind, body, and community. By addressing legal, economic, and cultural barriers, we can create a more inclusive and effective mental health system. This requires not only scientific validation but also a transformation in how we define, deliver, and value mental health care.